Besides, the inhibitory effects of Erastin and Sorafenib on cell proliferation were significantly enhanced by PTGDS knockdown in PTCL cells (Fig. 5d). The gene discussed is PTGDS; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.